The Meningitis Vaccine Project - frequently asked questions
Next steps
What are the Meningitis Vaccine Project's next steps?
In addition to actively seeking funding that will guarantee vaccine introduction throughout the whole meningitis belt, MVP is working closely both with governments and institutions in the African region, and international partners, to monitor the effect of the new vaccine on the ground. The project is also conducting further clinical research to inform policy, in particular for infants, to determine how best to integrate the meningococcal A conjugate vaccine into existing routine immunization programmes in Africa.